Form 8-K · Current report
Allstate 8-K, filed Aug 5, 2026
- Filed
- CIK
- 0000899051
- Accession no.
- 0000899051-26-000117
Summary
Allstate reported second-quarter 2026 revenues of $18.6 billion, net income applicable to common shareholders of $3.2 billion, and adjusted net income of $2.3 billion, or $8.99 per diluted share. Tom Wilson, who leads The Allstate Corporation, said the results reflected strategic growth plans and that share repurchases were increased to $1.0 billion for the quarter.
Key points
- Total revenues rose 11.8% year over year to $18.6 billion; net income applicable to common shareholders was $3.2 billion, up from $2.1 billion.
- Property-Liability earned premiums were $14.9 billion, up 4.0%, with underwriting income of $2.0 billion, compared with $1.3 billion a year earlier.
- Homeowners insurance underwriting income was $226 million, compared with a $76 million loss in the prior-year quarter, as catastrophe losses fell 12.8% to $1.4 billion.
- Protection Services revenues rose 7.8% to $935 million, while adjusted net income fell $7 million to $53 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. The Registrant’s press release dated August 5, 2026, announcing its financial results for the second quarter of 2026, and the Registrant’s second quarter 2026 investor supplement are furnished as Exhibits 99.1 and 99.2, respectively, to this report. The information contained in the press release and the investor supplement are furnished and not filed pursuant to instruction B.2 of Form 8-K. Section 9 – Financial Statements and Exhibits Item 9.01. Financial Statements and Exhibits. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.